News
Corona Remedies consolidated net profit rises 15.27% in the September 2026 quarter
31-Oct-2026 | 07:37
Sales rise 22.16% to Rs 441.17 crore
Net profit of Corona Remedies rose 15.27% to Rs 60.31 crore in the quarter ended September 2026 as against Rs 52.32 crore during the previous quarter ended September 2025. Sales rose 22.16% to Rs 441.17 crore in the quarter ended September 2026 as against Rs 361.13 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 441.17 | 361.13 | 22 |
| OPM % | 21.75 | 21.73 | - |
| PBDT | 95.81 | 78.98 | 21 |
| PBT | 80.75 | 69.78 | 16 |
| NP | 60.31 | 52.32 | 15 |
Powered by Capital Market - Live News